Ongoing research on ERMS focuses on improving treatment outcomes and understanding the underlying biology of the disease. Clinical trials are exploring new chemotherapy agents, targeted therapies, and immunotherapies. Researchers are also investigating the genetic and molecular mechanisms that drive ERMS, which may lead to more personalized and effective treatment strategies in the future.
